XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Total revenue $ 4,019 $ 1,312 $ 6,188 $ 2,465
Operating expenses:        
Research and development 56,011 31,569 100,767 58,831
General and administrative 14,512 12,952 28,250 24,787
Total operating expenses 70,523 44,521 129,017 83,618
Loss from operations (66,504) (43,209) (122,829) (81,153)
Other income (expense):        
Interest income 7,700 639 14,390 692
Other expense, net (97) (2) (238) (72)
Total other income, net 7,603 637 14,152 620
Loss before income taxes (58,901) (42,572) (108,677) (80,533)
Benefit from income taxes (4,306) (1,328) (7,218) (2,999)
Net loss $ (54,595) $ (41,244) $ (101,459) $ (77,534)
Basic (in dollars per share) $ (1.03) $ (0.88) $ (1.92) $ (1.66)
Diluted (in dollars per share) $ (1.03) $ (0.88) $ (1.92) $ (1.66)
Weighted-average ordinary shares outstanding used in per share calculations- basic (in shares) 53,121 46,805 52,812 46,755
Weighted-average ordinary shares outstanding used in per share calculations- diluted (in shares) 53,121 46,805 52,812 46,755
Collaboration revenue        
Total revenue $ 4,019 $ 1,312 $ 6,138 $ 2,415
Revenue from license and intellectual property        
Total revenue $ 0 $ 0 $ 50 $ 50